1. United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Publications; 2014.
2. United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Publications; 2013.
3. Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, Johns N, et al. The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010. Drug and Alcohol Dependence. 2014; 137:36–47. doi: 10.1016/j.drugalcdep.2013.12.025 [
DOI:10.1016/j.drugalcdep.2013.12.025]
4. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee SA, et al. Meth/amphetamine use and associated HIV: Implications for global policy and public health. International Journal of Drug Policy. 2010; 21(5):347–58. doi: 10.1016/j.drugpo.2009.11.007 [
DOI:10.1016/j.drugpo.2009.11.007]
5. Mehrjerdi ZA. Crystal in Iran: Methamphetamine or heroin kerack. DARU Journal of Pharmaceutical Sciences. 2013; 21(1):22. doi: 10.1186/2008-2231-21-22 [
DOI:10.1186/2008-2231-21-22]
6. Alam Mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian Journal of Psychiatry. 2015; 16:17–25. doi: 10.1016/j.ajp.2015.05.036 [
DOI:10.1016/j.ajp.2015.05.036]
7. Brensilver M, Heinzerling KG, Shoptaw S. Pharmacotherapy of amphetamine type stimulant dependence: An update. Drug and Alcohol Review. 2013; 32(5):449-60. doi: 10.1111/dar.12048 [
DOI:10.1111/dar.12048]
8. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014; 87:150–60. doi: 10.1016/j.neuropharm.2014.04.002 [
DOI:10.1016/j.neuropharm.2014.04.002]
9. Alam Mehrjerdi Z, Abarashi Z, Mansoori S, Deylamizadeh A, Salehi Fadardi J, Noroozi A, et al. Methamphetamine use among Iranian heroin kerack-dependent women: Implications for treatment. International Journal of High Risk Behaviors and Addiction. 2013; 2(1):15–21. doi: 10.5812/ijhrba.10216 [
DOI:10.5812/ijhrba.10216]
10. Alam Mehrjerdi Z, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine injecting treatment seekers: The first report from Iran. International Journal of STD & AIDS . 2013; 25(6):420–7. doi: 10.1177/0956462413512806 [
DOI:10.1177/0956462413512806]
11. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry. 2002; 59(9):817. doi: 10.1001/archpsyc.59.9.817 [
DOI:10.1001/archpsyc.59.9.817]
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). New York: American Psychiatric Pub; 2013.
13. Strauss A, Corbin J. Basics of qualitative research techniques. California: Sage Publications; 1998.
14. Noori R, Daneshmand R, Farhoudian A, Ghaderi S, Aryanfard S, Moradi A. Amphetamine type stimulants in a group of adults in Tehran, Iran: a rapid situation assessment in twenty-two districts. Iranian Journal of Psychiatry and Behavioural Sciences. 2016; 10(4):e7704. doi: 10.17795/ijpbs-7704 [
DOI:10.17795/ijpbs-7704]
15. Baker A, Boggs TG, Lewin TJ. Randomized controlled trial of brief cognitive behavioural interventions among regular users of amphetamine. Addiction. 2001; 96(9):1279–87. doi: 10.1046/j.1360-0443.2001.96912797.x [
DOI:10.1046/j.1360-0443.2001.96912797.x]
16. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction. 2005; 100(3):367–78. doi: 10.1111/j.1360-0443.2005.01002.x [
DOI:10.1111/j.1360-0443.2005.01002.x]
17. Massah O, Effatpanah M, Shishehgar S. Matrix model for methamphetamine dependence among Iranian female methadone patients: The first report from the most populated Persian Gulf country. Iranian Rehabilitation Journal. 2017; 15(3):193-8. [
DOI:10.29252/nrip.irj.15.3.193]
18. Sami S, Effatpanah M, Moradi A, Massah O. Matrix model as an intensive rehabilitation in three methadone services in Iran. Iranian Rehabilitation Journal. 2017; 15(3):293-8. [
DOI:10.29252/nrip.irj.15.3.293]
19. Noori R, Massah O, Moazen B, Farhoudian A, Daneshmand R, Aryanfard S. Women only therapeutic community program and treatment needs in Iran: The first study from the most populated Persian Gulf country. Iranian Journal of Psychiatry and Behavioural Sciences. 2017; 11(2): e9273. doi: 10.5812/ijpbs.9273
20. Hill R. Evidence based practices for treatment of methamphetamine dependency: A review. Guelph: Community Engaged Scholarship Institute; 2015.
21. Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli Casey PJ, et al. An intensive outpatient approach for cocaine abuse treatment. Journal of Substance Abuse Treatment. 1995; 12(2):117–27. doi: 10.1016/0740-5472(94)00080-b [
DOI:10.1016/0740-5472(94)00080-B]
22. Huber A, Ling W, Shoptaw S, Gulati V, Brethen P, Rawson R. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases. 1997; 16(4):41–50. Doi: 10.1080/10550889709511142 [
DOI:10.1080/10550889709511142]